Evidence map›Paper›PMID 41428222›Full record

ArticleUrolithiasis2025

Preoperative machine learning algorithm for predicting urosepsis after percutaneous nephrolithotomy using EMR data.

Bin Liang, Baofei Tan, Zuheng Wang, Kuan Pang, Guan Chen, Chunhua Liao, Beiyuan Huang, Zhenqiang Zhang, Xingze Liu, Qiang Ling and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bin Liang *Department of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Baofei Tan *Department of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Zuheng Wang *Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, No. 22, Shuangyong Road, Qingxiu District, Nanning, 530021, Guangxi, China.
Kuan PangDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Guan ChenDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Chunhua LiaoDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Beiyuan HuangDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Zhenqiang ZhangDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Xingze LiuDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Qiang LingDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China.
Wenhao LuCollaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, No. 22, Shuangyong Road, Qingxiu District, Nanning, 530021, Guangxi, China.
Xiao LiSchool of Life Sciences, Guangxi Medical University, No. 22, Shuangyong Road, Qingxiu District, Nanning, 530021, Guangxi, China.
Fubo WangDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China. wangfubo@gxmu.edu.cn.
Guijian PangDepartment of Urology, the First People's Hospital of Yulin (the Sixth Affiliated Hospital of Guangxi Medical University), No. 495, Education Middle Road, Yuzhou District, Yulin, 537000, Guangxi, China. pangguijian@163.com.

Funding

Science and Technology Major Project of Guangxi AA22096032Science Fund for Distinguished Young Scholars of Guangxi Province 2023GXNSFFA026003
6 · The paper itself

Abstract

Urosepsis is one of the most severe complications after percutaneous nephrolithotomy (PNL). This study aimed to develop and validate a preoperative machine learning (ML) model for predicting post-PNL urosepsis using electronic medical record (EMR) data. In this retrospective study, we included 360 patients with urosepsis and 2,636 without urosepsis. Multimodal clinical parameters were collected, including demographic data, admission vital signs, imaging reports, and laboratory results. The cohort was randomly split into a training set (80%) and a validation set (20%). Eight ML algorithms were used to build prediction models, with performance evaluated via receiver operating characteristic (ROC) curves. In the training set, the LightGBM, RF, and XGBoost models showed the highest accuracy, each achieving an Area Under the ROC Curve (AUC) of 1.00. In contrast, the LR model performed best in the validation set (AUC = 0.77, 95% CI: 0.64–0.91). The key predictors for the LR model included heart rate (HR), serum creatinine (Scr), venous thromboembolism (VTE), urine leukocytes (U-LEU), and body mass index (BMI), which were part of 19 total predictive parameters. In conclusion, we developed an ML model using 19 preoperative EMR-derived parameters to predict post-PNL urosepsis risk. This model may help clinicians identify high-risk patients preoperatively, enabling timely interventions to reduce PNL-associated mortality.

Indexed as

Machine LearningNephrolithotomy, PercutaneousPostoperative ComplicationsSepsisUrinary Tract InfectionsAdultBoosting Machine Learning AlgorithmsClassification AlgorithmsElectronic Health RecordsFemaleHumansKidney CalculiMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsElectronic medical recordsMachine learningPercutaneous nephrolithotomyUpper urinary calculiUrosepsis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.